Filiberto Zadini
Keine laufenden Positionen mehr
Profil
Dr. Filiberto Zadini, MD, is on the Board of Directors at AtheroNova, Inc. Dr. Zadini also served on the board at Trist Holdings, Inc.
Ehemalige bekannte Positionen von Filiberto Zadini
Unternehmen | Position | Ende |
---|---|---|
ATHERONOVA INC. | Gründer | 25.02.2011 |
Trist Holdings, Inc.
Trist Holdings, Inc. Medical/Nursing ServicesHealth Services Trist Holdings, Inc. does not have significant operations. The company intends to seek a suitable candidate for a business combination with a private company. Previously, it was engaged in acquisition of parcels of land primarily through the real property tax lien foreclosure process. The company was formerly known as Landbank Group, Inc. and changed its name to Trist Holdings, Inc. in December 2007. Trist Holdings, Inc. was incorporated in 1997 and is based in Newport Beach, California | Direktor/Vorstandsmitglied | 25.05.2010 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Trist Holdings, Inc.
Trist Holdings, Inc. Medical/Nursing ServicesHealth Services Trist Holdings, Inc. does not have significant operations. The company intends to seek a suitable candidate for a business combination with a private company. Previously, it was engaged in acquisition of parcels of land primarily through the real property tax lien foreclosure process. The company was formerly known as Landbank Group, Inc. and changed its name to Trist Holdings, Inc. in December 2007. Trist Holdings, Inc. was incorporated in 1997 and is based in Newport Beach, California | Health Services |
AtheroNova, Inc.
AtheroNova, Inc. Pharmaceuticals: MajorHealth Technology AtheroNova, Inc. operates as biotechnology company. The company engages in the research and development, marketing, and sale of pharmaceutical preparations and pharmaceutical intellectual property. It develops intellectual property that uses certain pharmacological compounds for the treatment of atherosclerosis, which is the primary cause of various cardiovascular diseases. The company was founded by Giorgio Zadini and Filiberto Zadini in 1997 and is headquartered in Irvine, CA. | Health Technology |